Related Experiment Video
Updated: May 4, 2026

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
Published on: May 12, 2020
Mitochondrial and postmitochondrial survival signaling in cancer
1Department of Pharmacology Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, United States.
Abstract:
Cancer cells are resistant to conventional chemotherapy and radiotherapy, however, the molecular mechanisms of resistance to therapy remain unclear. Cellular survival machinery protects mitochondrial integrity against endogenous or exogenous stresses. Prodeath molecules orchestrate around mitochondria to initiate and execute cell death in cancer, and also play an underappreciated role in survival of cancer cells. Prosurvival mechanisms can operate at mitochondrial and postmitochondrial levels to attenuate core apoptotic death program. It is intriguing to explore how prosurvival and prodeath molecules crosstalk to regulate mitochondrial functions leading to increased cancer cell survival. This review describes some putative survival mechanisms at mitochondria, which may play a role in designing effective agents for cancer prevention and therapy. These survival pathways may also have significance in understanding other human pathophysiological conditions including diabetes, cardiovascular, autoimmune, and neurodegenerative diseases.
Insights
Cancer cells resist therapy through complex survival mechanisms involving mitochondria. Understanding the crosstalk between pro-survival and pro-death molecules is key to developing new cancer treatments.
Area of Science:
- Mitochondrial biology
- Cancer cell biology
- Molecular mechanisms of disease
Background:
- Cancer cells exhibit resistance to conventional chemotherapy and radiotherapy.
- The precise molecular mechanisms underlying therapeutic resistance in cancer remain incompletely understood.
- Cellular machinery protects mitochondrial integrity against various stresses, influencing cancer cell survival.
Purpose of the Study:
- To explore the intricate crosstalk between prosurvival and prodeath molecules.
- To elucidate how this molecular crosstalk regulates mitochondrial functions and enhances cancer cell survival.
- To identify putative survival mechanisms at the mitochondria for designing effective cancer therapies.
Main Methods:
- This is a review article, synthesizing existing research.
- Analysis of molecular pathways regulating mitochondrial integrity and apoptosis.
- Exploration of the interplay between pro-survival and pro-death signaling in cancer.
Main Results:
- Prodeath molecules, while initiating cell death, also contribute to cancer cell survival.
- Prosurvival mechanisms operate at both mitochondrial and postmitochondrial levels to counteract apoptosis.
- The crosstalk between these molecular players dictates cancer cell fate and therapeutic response.
Conclusions:
- Mitochondrial survival pathways are critical targets for novel cancer prevention and therapy development.
- Understanding these mechanisms can lead to more effective anti-cancer agents.
- These pathways may also be relevant to other diseases like diabetes and neurodegeneration.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...